Month: September 2024

[ad_1] Fulcrum rises after BofA upgrades rating on chance of FSHD study success [ad_2] Source: Seekingalpha

[ad_1] CVS, Humana dip amid new mental health tips, Leerink note [ad_2] Source: Seekingalpha

[ad_1] J&J Rybrevant/Lazcluze study shows superiority over Tagrisso [ad_2] Source: Seekingalpha

[ad_1] Summit a ‘top pick’ at Citi after ‘unprecedented’ trial outcomes, bull rally [ad_2] Source: Seekingalpha

[ad_1] Xencor stock rallies 24% amid drug development updates [ad_2] Source: Seekingalpha

[ad_1] Relay Therapeutics (NASDAQ:RLAY) on Monday mentioned it has commenced an underwritten public offering of $200 million of shares of its common stock. Relay Therapeutics additionally…

[ad_1] designer491/iStock by way of Getty Images Immunovant (NASDAQ:IMVT) stock fell 8% Monday after it reported knowledge from a Phase 2a research of batoclimab within the…

[ad_1] Catalyst Watch: Apple’s iPhone occasion, Oracle earnings, Google antitrust trial, and the August CPI print [ad_2] Source: Seekingalpha

[ad_1] Tenon Medical stock falls following 8-for-1 reverse split [ad_2] Source: Seekingalpha

[ad_1] Applied DNA stock jumps amid U.S. government mpox update [ad_2] Source: Seekingalpha